Skip to main content
SpringerLink
Log in

CORP-2-Studie

Colchizin halbiert das Risiko für chronisch rezidivierende Perikarditiden

CORP-2 study

Colchicine halves the risk for chronic recurrent pericarditis

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Imazio M, Brucato A, Cemin R et al (2013) A randomized trial of colchicine for acute pericarditis. N Engl J Med 369:1522–1528

    Article  CAS  PubMed  Google Scholar 

  2. Imazio M, Belli R, Brucato A et al (2014) Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial. Lancet 383:2232–2237

    Article  CAS  PubMed  Google Scholar 

  3. Maisch B, Seferovic PM, Ristic AD et al (2004) Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J 25:587–610

    Article  PubMed  Google Scholar 

  4. Cacoub PP (2014) Colchicine for treatment of acute or recurrent pericarditis. Lancet 383:2193–2194

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

C. Özcelik gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Herzverbund Südniedersachsen, Helios Albert-Schweitzer-Klinik, Sturmbäume 8, 37154, Northeim, Deutschland

    C. Özcelik

Authors
  1. C. Özcelik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Özcelik.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Özcelik, C. CORP-2-Studie. Kardiologe 8, 285–287 (2014). https://doi.org/10.1007/s12181-014-0585-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-014-0585-9

Search

Navigation